
American firearms manufacturer Smith & Wesson (NASDAQ: SWBI) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 32.3% year on year to $112.6 million. Its non-GAAP profit of $0.06 per share was significantly above analysts’ consensus estimates.
Is now the time to buy Smith & Wesson? Find out by accessing our full research report, it’s free.
Smith & Wesson (SWBI) Q2 CY2026 Highlights:
- Revenue: $112.6 million vs analyst estimates of $98.7 million (32.3% year-on-year growth, 14.1% beat)
- Adjusted EPS: $0.06 vs analyst estimates of -$0.05 (significant beat)
- Adjusted EBITDA: $13.77 million vs analyst estimates of $5.99 million (12.2% margin, significant beat)
- Operating Margin: 3.7%, up from -3.5% in the same quarter last year
- Free Cash Flow was -$20.78 million compared to -$12.4 million in the same quarter last year
- Market Capitalization: $571.6 million
Company Overview
With a history dating back to 1852, Smith & Wesson (NASDAQ: SWBI) is a firearms manufacturer known for its handguns and rifles.
Revenue Growth
A company’s long-term sales performance is one signal of its overall quality. Any business can experience short-term success, but top-performing ones enjoy sustained growth for years. Over the last five years, Smith & Wesson’s demand was weak and its revenue declined by 13% per year. This was below our standards and suggests it’s a low quality business.

We at StockStory place the most emphasis on long-term growth, but within consumer discretionary, a stretched historical view may miss a company riding a successful new product or trend. Smith & Wesson’s annualized revenue growth of 4% over the last two years is above its five-year trend, which is encouraging. 
This quarter, Smith & Wesson reported wonderful year-on-year revenue growth of 32.3%, and its $112.6 million of revenue exceeded Wall Street’s estimates by 14.1%.
Looking ahead, sell-side analysts expect revenue to grow 3.1% over the next 12 months, similar to its two-year rate. This projection doesn’t excite us and implies its newer products and services will not catalyze better top-line performance yet.
ALSO WORTH WATCHING: Nvidia’s Quiet Partner. Nvidia’s chips cost a hundred grand. The connectors that make them work cost even more. One company makes them all.
Every AI server needs specialized infrastructure the chip companies don’t make. High-speed cables. Power connectors. Thermal sensors. This 90-year-old company built a monopoly on it. The AI boom just started. This stock is still flying under the radar. Claim The Stock Ticker Here for FREE.
Operating Margin
Smith & Wesson’s operating margin has risen over the last 12 months and averaged 5.7% over the last two years. The company’s higher efficiency is a breath of fresh air, but its suboptimal cost structure means it still sports inadequate profitability for a consumer discretionary business.

This quarter, Smith & Wesson generated an operating margin profit margin of 3.7%, up 7.3 percentage points year on year. This increase was a welcome development and shows it was more efficient.
Earnings Per Share
We track the long-term change in earnings per share (EPS) for the same reason as long-term revenue growth. Compared to revenue, however, EPS highlights whether a company’s growth is profitable.
Sadly for Smith & Wesson, its EPS declined by 36.7% annually over the last five years, more than its revenue. This tells us the company struggled because its fixed cost base made it difficult to adjust to shrinking demand.

In Q2, Smith & Wesson reported adjusted EPS of $0.06, up from negative $0.08 in the same quarter last year. This print easily cleared analysts’ estimates, and shareholders should be content with the results. We also like to analyze expected EPS growth based on Wall Street analysts’ consensus projections, but there is insufficient data.
Key Takeaways from Smith & Wesson’s Q2 Results
It was good to see Smith & Wesson beat analysts’ EPS expectations this quarter. We were also excited its EBITDA outperformed Wall Street’s estimates by a wide margin. Zooming out, we think this was a good print with some key areas of upside. The stock traded up 7.5% to $13.30 immediately after reporting.
Smith & Wesson put up rock-solid earnings, but one quarter doesn’t necessarily make the stock a buy. Let’s see if this is a good investment. The latest quarter does matter, but not nearly as much as longer-term fundamentals and valuation, when deciding if the stock is a buy. We cover that in our actionable full research report which you can read here (it’s free).
